Skip to content
Clinical Trials – home

Intermax Sp. z o.o.

Research site

Poland Ul. 1 Maja 27, 42-217 Czestochowa, Poland

  • Cholangitis sclerosing · Cholestatic pruritus · Primary biliary cholangitis
  • Adult patients

About Specializations

Intermax Sp. z o.o. in Czestochowa, Poland specialises in clinical trials of conditions such as Cholangitis sclerosing, Cholestatic pruritus, Primary biliary cholangitis, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Diseases

At Intermax Sp. z o.o. in Czestochowa, Poland, clinical research is focused on digestive system diseases, with a particular emphasis on cholestasis and primary sclerosing cholangitis. The studies are designed to better understand these liver and bile duct conditions while assessing new treatment options for patients with ongoing symptoms.

  • Evaluation of treatments for cholestatic pruritus in people with primary biliary cholangitis
  • Research in primary sclerosing cholangitis with and without clinically relevant strictures
  • Safety and tolerability studies aimed at improving treatment options for chronic hepatobiliary disease

The site’s work centers on testing whether newer therapies can be used safely over time and whether they may help improve symptom control and disease management in patients with complex gastroenterological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. 1 Maja 2742-217 CzestochowaPoland
Recruiting now
no trials
Conditions studied
3

More sites in CzestochowaPoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study on the Safety and Tolerability of A3907 for Adults with Primary Sclerosing Cholangitis (PSC)

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:A3907
  • Sponsor:Albireo AB

Study on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Linerixibat
  • Sponsor:Glaxosmithkline Research & Development Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.